Abstract
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Potesil J, Kopriva F, Dzubak P, et al. Expression of multidrug resistance protein 1 and multidrug resistance-associated protein 1 in peripheral blood lymphocytes amongst children and young adults. Central European Journal of Immunology. 2013;38(4):518-529. doi:10.5114/ceji.2013.39770. APA Potesil, J., Kopriva, F., Dzubak, P., Godava, M., Radova, L., & Srovnal, J. et al. (2013). Expression of multidrug resistance protein 1 and multidrug resistance-associated protein 1 in peripheral blood lymphocytes amongst children and young adults. Central European Journal of Immunology, 38(4), 518-529. https://doi.org/10.5114/ceji.2013.39770 Chicago Potesil, Jan, Frantisek Kopriva, Petr Dzubak, Marek Godava, Lenka Radova, Josef Srovnal, and Vladimir Mihal et al. 2013. "Expression of multidrug resistance protein 1 and multidrug resistance-associated protein 1 in peripheral blood lymphocytes amongst children and young adults". Central European Journal of Immunology 38 (4): 518-529. doi:10.5114/ceji.2013.39770. Harvard Potesil, J., Kopriva, F., Dzubak, P., Godava, M., Radova, L., Srovnal, J., Mihal, V., and Hajduch, M. (2013). Expression of multidrug resistance protein 1 and multidrug resistance-associated protein 1 in peripheral blood lymphocytes amongst children and young adults. Central European Journal of Immunology, 38(4), pp.518-529. https://doi.org/10.5114/ceji.2013.39770 MLA Potesil, Jan et al. "Expression of multidrug resistance protein 1 and multidrug resistance-associated protein 1 in peripheral blood lymphocytes amongst children and young adults." Central European Journal of Immunology, vol. 38, no. 4, 2013, pp. 518-529. doi:10.5114/ceji.2013.39770. Vancouver Potesil J, Kopriva F, Dzubak P, Godava M, Radova L, Srovnal J et al. Expression of multidrug resistance protein 1 and multidrug resistance-associated protein 1 in peripheral blood lymphocytes amongst children and young adults. Central European Journal of Immunology. 2013;38(4):518-529. doi:10.5114/ceji.2013.39770.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
